Literature DB >> 9826674

An essential role of phosphatidylinositol 3-kinase in myogenic differentiation.

B H Jiang1, J Z Zheng, P K Vogt.   

Abstract

The oncogene p3k, coding for a constitutively active form of phosphatidylinositol 3-kinase (PI 3-kinase; EC 2.7.1.137), strongly enhances myogenic differentiation in cultures of chicken-embryo myoblasts. It increases the size of the myotubes and induces elevated levels of the muscle-specific proteins MyoD, myosin heavy chain, creatine kinase, and desmin. Inhibition of PI 3-kinase activity with LY294002 or with dominant-negative mutants of PI 3-kinase interferes with myogenic differentiation and with the induction of muscle-specific genes. PI 3-kinase is therefore an upstream mediator for the expression of the muscle-specific genes and is both necessary and rate-limiting for the process of myogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826674      PMCID: PMC24347          DOI: 10.1073/pnas.95.24.14179

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Transcription of muscle-specific genes is repressed by reactivation of pp60v-src in postmitotic quail myotubes.

Authors:  G Falcone; S Alemà; F Tatò
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

Review 2.  Interaction of oncogenes with differentiation programs.

Authors:  D Boettiger
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

3.  Cell proliferation inhibited by MyoD1 independently of myogenic differentiation.

Authors:  V Sorrentino; R Pepperkok; R L Davis; W Ansorge; L Philipson
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

4.  The viral and cellular Rel oncoproteins induce the differentiation of P19 embryonal carcinoma cells.

Authors:  M Inuzuka; H Ishikawa; S Kumar; C Gélinas; Y Ito
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

Review 5.  The myoD gene family: nodal point during specification of the muscle cell lineage.

Authors:  H Weintraub; R Davis; S Tapscott; M Thayer; M Krause; R Benezra; T K Blackwell; D Turner; R Rupp; S Hollenberg
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

6.  v-jun oncogene prevents terminal differentiation and suppresses muscle-specific gene expression in ASV-17-infected muscle cells.

Authors:  M Grossi; A Calconi; F Tatò
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

7.  Jun inhibits myogenic differentiation.

Authors:  H Y Su; T J Bos; F S Monteclaro; P K Vogt
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

8.  c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation.

Authors:  J H Miner; B J Wold
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

9.  Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases.

Authors:  S M Thomas; M DeMarco; G D'Arcangelo; S Halegoua; J S Brugge
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

10.  Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C.

Authors:  T B Vaidya; C M Weyman; D Teegarden; C L Ashendel; E J Taparowsky
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

View more
  37 in total

1.  A role of tensin in skeletal-muscle regeneration.

Authors:  A Ishii; S H Lo
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

2.  A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

Authors:  U Delling; J Tureckova; H W Lim; L J De Windt; P Rotwein; J D Molkentin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation.

Authors:  Alexias Safi; Marie Vandromme; Sabine Caussanel; Laure Valdacci; Dominique Baas; Marc Vidal; Gilbert Brun; Laurent Schaeffer; Evelyne Goillot
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

4.  AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.

Authors:  Mathivanan Jothi; Kochi Nishijo; Charles Keller; Asoke K Mal
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

5.  O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling.

Authors:  Amar J Majmundar; Nicolas Skuli; Rickson C Mesquita; Meeri N Kim; Arjun G Yodh; Michelle Nguyen-McCarty; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

6.  Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B.

Authors:  B H Jiang; M Aoki; J Z Zheng; J Li; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Biphasic regulation of intracellular calcium by gemfibrozil contributes to inhibiting L6 myoblast differentiation: implications for clinical myotoxicity.

Authors:  Aiming Liu; Julin Yang; Frank J Gonzalez; Gary Q Cheng; Renke Dai
Journal:  Chem Res Toxicol       Date:  2010-12-22       Impact factor: 3.739

Review 8.  MicroRNAs in skeletal myogenesis.

Authors:  Yejing Ge; Jie Chen
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

9.  ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.

Authors:  Peggy Lafuste; Corinne Sonnet; Bénédicte Chazaud; Patrick A Dreyfus; Romain K Gherardi; Ulla M Wewer; François-Jérôme Authier
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

10.  Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis.

Authors:  Ivelisse Gonzalez; Gyanendra Tripathi; Emma J Carter; Laura J Cobb; Dervis A M Salih; Fiona A Lovett; Cathy Holding; Jennifer M Pell
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.